Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Buy
62
SPHDF Quote, Financials, Valuation and Earnings
Last price:
$21.15
Seasonality move
:
7.29%
Day range:
$21.15 - $21.15
52-week range:
$9.42 - $22.04
Dividend yield:
0%
P/E ratio:
1.45x
P/S ratio:
4.78x
P/B ratio:
7.72x
Volume:
--
Avg. volume:
207
1-year change:
124.52%
Market cap:
$274.4M
Revenue:
$44.4M
EPS (TTM):
-$4.43
Earnings Data
Next earnings date for SPHDF
--
Most recent earnings per share
-$16.77
Missed by $16.77
(Dec 31/2018)
Consensus Estimate
--
(Dec 31/2018)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SPHDF Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 12/31/2018 | Q4 | -- | $8.1M | -$16.77 | -- | -- |
| 09/30/2018 | Q3 | -- | $7.7M | -$19.72 | -- | -- |
| 12/31/2017 | Q4 | -- | $6.7M | -$29.37 | -- | -- |
| 09/30/2017 | Q3 | -- | $5.7M | -$17.56 | -- | -- |
Santhera Pharmaceuticals Holding AG Earnings Questions
-
How Much did Santhera Pharmaceuticals Holding AG Generate in Revenue Last Quarter?
Santhera Pharmaceuticals Holding AG reported $8.1M worth of top line sales in its most recent quarter.
-
Did Santhera Pharmaceuticals Holding AG Beat Earnings Last Quarter?
Santhera Pharmaceuticals Holding AG announced earnings per share of -$16.77 which represents a miss of analyst forecast a -- per share.
-
Is Santhera Pharmaceuticals Holding AG Profitable?
Santhera Pharmaceuticals Holding AG reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Santhera Pharmaceuticals Holding AG EPS Next Year?
Santhera Pharmaceuticals Holding AG's earnings are forecast to grow from -$4.19 per share to -- per share next year representing an increase of --.
-
When is Santhera Pharmaceuticals Holding AG's Earnings Date?
Currently, Santhera Pharmaceuticals Holding AG has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on June 4, 2026.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
49
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 37x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
42
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Buy
93
NBTX alert for Mar 5
Nanobiotix SA [NBTX] is down 5.4% over the past day.
Sell
45
MRNA alert for Mar 5
Moderna, Inc. [MRNA] is down 8.3% over the past day.
Buy
77
SSRM alert for Mar 5
SSR Mining, Inc. [SSRM] is down 7.49% over the past day.
